International Patent: BISPECIFIC ANTIBODY TARGETING EGFR AND C-MET, ANTIBODY-DRUG CONJUGATE THEREOF, AND USE THEREOF

GENEVA, July 9 -- INNOVENT BIOPHARMACEUTICALS (HANGZHOU) CO., LTD. filed a patent application (CN2025/147936) for “BISPECIFIC ANTIBODY TARGETING EGFR AND C-MET, ANTIBODY-DRUG CONJUGATE THEREOF, AND USE THEREOF”. With publication no. WO/2026/145674, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....